Futura Medical Investors - FUM

Futura Medical Investors - FUM

Buy
Sell
Best deals to access real time data!
Silver
Monthly Subscription
for only
£17.37
Level 2 Basic
Monthly Subscription
for only
£62.08
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Futura Medical Plc FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change Price Change % Stock Price Last Trade
1.50 2.8% 55.00 16:35:00
Open Price Low Price High Price Close Price Previous Close
52.00 52.00 59.00 55.00 53.50
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Top Investor Posts

DateSubject
01/4/2021
18:22
lbo: As previously said https://www.investorvillage.com/smbd.asp?mb=16353&mn=6435&pt=msg&mid=13899702 LBO - 25 Mar 2021 - 11:44:31 - 9137 of 9255 Really? The way the Co-High financial deal was structured it has cost them nothing as they can sell on the loan to a fund that can short the shares all the way back down to the conversion price and then have no capital outlay on the loan. If the share price is kept above 30p then the loan converts at 20p into 7.5m shares. Sell 3m shares less above 50p and then get 7.5m later at 20p. And what new investor or shareholder would pay more then 20-30p based on that valuation deal in any upcoming placing? Co-High could also buy more in a discounted placing if they wanted any more shares or they just sit on the Futura contract without having to go to the cost of doing the China studies or launching it ever. Its a free bet for a investment company not a company that specialises in distribution of similar products in China. Unlike the CSD500 deal which was at least with a recognised company in Ansell and under a brand like Jissbon. But still that didn’t generate any Revenue for Futura. If we see similar small time distribution deals with MED300 as happened with CSD500 then we won’t see any significant upfront cash from those deals. So they need to do a placing. https://www.lewissilkin.com/en/insights/convertible-loan-notes-and-or-advance-subscription-agreements-as-a-source-of-emergency-funding-faqs https://www.agiocapsol.com/en/newsroom/agio-capital-business-solutions-successfully-supported-the-investment-in-uk-listed-company-futura-medical-and-joint-collaboration-for-greater-china-south-east-asia/ Agio introduced Futura Medical to potential Chinese strategic partners and investors and supported the financial transaction from Atlantis Investment Management as well as the negotiations with Co-High Investment Management. Our offering includes: Organise and schedule investor meetings or road shows
31/3/2021
21:57
lbo: Always DYOR https://link.springer.com/article/10.1007/s10198-016-0820-3 Medical devices (MDs) often obtain market authorization with much less clinical evidence than other health technologies, especially pharmaceuticals. This is due to a number of reasons. First, in contrast to pharmaceuticals, there is no legal requirement to conduct adequately controlled clinical studies, other than for ‘high-risk’ devices in some jurisdictions. In the US for example, high-risk devices and innovative lower-risk devices are required to demonstrate ‘reasonable assurance of safety and effectiveness’, which may imply clinical evidence based on randomized studies in many instances. In contrast, in the EU the requirement is to demonstrate adequate performance and safety, which can often be achieved by conducting observational studies such as registries https://www.the-scientist.com/news-opinion/sec-charges-ubiome-founders-with-defrauding-investors-68583 https://www.thetimes.co.uk/article/ubiome-scandal-gives-silicon-valley-a-kick-in-the-guts-nmkdtj6kv
31/3/2021
11:07
j777j: Anyway what we do know is.. "The Company has now received initial offers from a number of parties and believes the EU approval of MED3000 will assist the Company in its objective of delivering long-term, sustainable value through the licensing of MED3000." Also the Chinese have committed up to £6 million towards launching into China. They run a specialised health care fund and have put their money where their mouth is. I think I will add as newsflow is imminent on a number of fronts. ps Re Cannabidiol,you clearly havent done your research as those investors are experienced players.They set up a separate co specifically to JV with Fum. You are making it out as cloak and dagger when that is simply not the case.In any event they are working on a product which could become the key ingredient in all topically applied cannabidiol products.
29/3/2021
11:18
kinwah: LBO reminds me of the Rita Webb character, Cassandra in the film Up Pompeii. She was a prophet of doom but was proved right in the end. LBO obviously knows the company well and I enjoy reading his posts. Sometimes knowing a company well or having too much information can stop you making money from a share as you focus on all the negative aspects and ignore the blue sky which other investors are looking at. Any competent investor should be able to consider LBO's views and the more bullish viewpoints and reach their own conclusion.
27/3/2021
17:43
ryad123: No investment is risk free and any product no matter its merits can only succeed if it meets a need or it gains traction among consumers, which is why sensible investors will diversify and not pin their hopes on any single stock. @Ibo i dont get why you keep repeating your point many times a day, if you think this stock is heading south then open a short position and wait for the pay cheque, those who think otherwise can hold or buy more, you seem rather emotionally attached to this share, remember the share doesnt know you own it, if you care about being right then become a philosopher or a preacher not an investor or a trader, if you lost money here move on to something else, you dont have to make it the way you lost it!
26/3/2021
11:01
lbo: If they do manage to pull the wool over the eyes of some investors yet again then I must say it would be quite impressive how they do just keep managing to find new suckers to invest. But I think it says more about the caliber of investors around at the moment. https://www.theguardian.com/business/2021/mar/23/new-breed-of-young-investors-taking-big-risks-warns-fca-bitcoin-foreign-exchange But as you said its all about money and keeping the Futura gravy train wreck on the tracks for as long as they all can. https://atlantis-investment.com/files/file/??Factsheet202006_EN.pdf
24/3/2021
16:51
sphere25: Better post this as a follow up to show what is going on out there: https://www.theguardian.com/business/2021/mar/23/new-breed-of-young-investors-taking-big-risks-warns-fca-bitcoin-foreign-exchange There is some very scary stuff in there: "In the FCA-commissioned report, researchers from the consultancy BritainThinks uncovered a “striking” lack of awareness or genuine belief in the hazards associated with investing, with 45% of those questioned not viewing “losing some money” as a potential risk."
23/3/2021
13:20
kinwah: I think the price action is very encouraging. After a huge rise on big volume you expect to see profit taking. Quite often you can be rapidly back to where you started from but FUM has seen new buyers come in after the pullbacks. The shareholder list is likely to have seen substantial change over the last 3 days. You'll have new private investors like me buying on a medium term view but I think there's been some longer term institutional buying. In other words I don't think this is all hot money looking for a quick turn.
08/3/2021
18:49
leewain: Good points, butler, something investors should take note of. Loads of scenarios and definately NOT clear cut. Why did ST bail out before the results of the phase 3 trial. Enough said.
23/2/2021
20:12
dazza2311: What a clown Jonnybag is. He is getting increasingly desperate now. Next he will be saying that investors are mixing up Tesla and Tesco. Everyone is laughing at you Jonnybag and your many aliases. LOL LOL LOL LOL LOL LOL LOL.
ADVFN Advertorial
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210413 15:51:55